Anzeige
Meldung des Tages: Milliardenmarkt, eigene KI-Plattform, starke Kasse: Ist diese Aktie massiv unterbewertet?

CollPlant Biotechnologies News

Aktie
WKN:  A1CY27 ISIN:  IL0004960188 US-Symbol:  CLGN Branche:  Biotechnologie Land:  Israel
0,5401 $
-0,0249 $
-4,41%
0,457 € 27.02.26
Depot/Watchlist
Marktkapitalisierung *
16,44 Mio. €
Streubesitz
77,61%
KGV
-2,48
Index-Zuordnung
-

CollPlant Biotechnologies News

26.02.26 - PR Newswire
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler PR Newswire
23.02.26 - PR Newswire
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-​to-Print BioFlex PR Newswire
17.02.26 - PR Newswire
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-​Loss Treatments PR Newswire
05.02.26 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING PR Newswire
26.11.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
18.11.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS PR Newswire
27.10.25 - PR Newswire
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada PR Newswire
20.10.25 - PR Newswire
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
CollPlant's rhCollagen-​Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology PR Newswire
16.10.25 - PR Newswire
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
First-​in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-​Based BioInk PR Newswire
30.09.25 - PR Newswire
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
CollPlant Biotechnologies Announces Positive Results from non-​clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler PR Newswire
15.09.25 - PR Newswire
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
CollPlant Expands the Distribution of its VergenixSTR Product in Europe PR Newswire
02.09.25 - PR Newswire
CollPlant to Present at the 2025 International Conference on Biofabrication
CollPlant to Present at the 2025 International Conference on Biofabrication PR Newswire
25.08.25 - PR Newswire
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference PR Newswire
20.08.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
05.08.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS PR Newswire
14.07.25 - PR Newswire
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations PR Newswire
09.06.25 - PR Newswire
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES PR Newswire
04.06.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-​BASED FORMULATIONS USABLE AS SOFT TISSUE ...
30.05.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-​THE-MARKET UNDER NASDAQ RULES PR Newswire
28.05.25 - PR Newswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE PR Newswire

Newssuche

Videos

newspaper
25.02.26
So beeinflussen Margins DEIN Trading
Börsentäglich ab 18 Uhr Feierabend-​Trading Live. Teilnahme kostenlos mit diesem Link ... Mehr »